Commonwealth Equity Services’s Bionano Genomics BNGO Stock Holding History

Commonwealth Equity Services’s Portfolio BNGO Stock Details BNGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-81	Closed	-$30K	–	3838
2023 Q2	$30K	Buy	81 +10	+14%	+$4.51K	﹤0.01%	3718
2023 Q1	$47	Sell	71 -6	-8%	-$5.33K	﹤0.01%	3586
2022 Q4	$67K	Buy	77 +4	+5%	+$5.03K	﹤0.01%	3475
2022 Q3	$80K	Buy	73 +9	+14%	+$11.9K	﹤0.01%	3414
2022 Q2	$53K	Buy	64 +6	+10%	+$6.17K	﹤0.01%	3474
2022 Q1	$89K	Sell	58 -28	-33%	-$37.8K	﹤0.01%	3513
2021 Q4	$155K	Sell	86 -11	-11%	-$29.4K	﹤0.01%	3364
2021 Q3	$319K	Buy	97 +6	+7%	+$21K	﹤0.01%	2863
2021 Q2	$402K	Buy	91 +2	+2%	+$7.9K	﹤0.01%	2642
2021 Q1	$429K	Buy	89 +13	+17%	+$73.3K	﹤0.01%	2452
2020 Q4	$140K	Buy	+76	New	+$28.4K	﹤0.01%	3012

Other funds holding BNGO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Mitsubishi UFJ Asset Management Tokyo, Japan $149B AUM 24.71% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Commonwealth Equity Services's BNGO Position: Q3 2023 in Review

Commonwealth Equity Services sold out of Bionano Genomics (BNGO) in Q3 2023, closing a stake of 81 shares — an estimated $30K sold.

Commonwealth Equity Services first reported a position in BNGO in Q4 2020 and held it in 11 quarters. The position peaked at $429K in Q1 2021. 46 funds tracked by Wall St. Rank hold BNGO as of Q3 2023.

Commonwealth Equity Services reported no remaining Bionano Genomics position as of Q3 2023 after selling out during the quarter.
Commonwealth Equity Services sold 81 Bionano Genomics shares in Q3 2023, an estimated $30K.
Commonwealth Equity Services first reported a position in Bionano Genomics in Q4 2020 and held it in 11 quarters.
Commonwealth Equity Services's Bionano Genomics position peaked at $429K in Q1 2021.
46 funds tracked by Wall St. Rank held Bionano Genomics as of Q3 2023.

Based on Commonwealth Equity Services's 13F filing for Q3 2023, filed 23 Oct 2023.